Treating gliosis, glial scarring, inflammation or inhibition of axonal growth in the nervous system by modulating eph receptor

Details for Australian Patent Application No. 2005282217 (hide)

Owner The University of Queensland The University of Melbourne

Inventors Bartlett, Perry F.; Goldshmit, Yona; Boyd, Andrew W.; Turnley, Ann M.; Galea, Mary P.

Agent Davies Collison Cave

Pub. Number AU-B-2005282217

PCT Pub. Number WO2006/026820

Priority 60/647,968 27.01.05 US; 2004905148 08.09.04 AU

Filing date 8 September 2005

Wipo publication date 16 March 2006

Acceptance publication date 31 May 2012

International Classifications

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 31/7105 (2006.01) - Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links

A61K 38/17 (2006.01) Medicinal preparations containing peptides - from animals

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

Event Publications

22 February 2007 PCT application entered the National Phase

  PCT publication WO2006/026820 Priority application(s): WO2006/026820

31 May 2012 Application Accepted

  Published as AU-B-2005282217

27 September 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005282218-Therapeutic strategy for treating autoimmune and degenerative diseases

2005282216-Pressure leaching system and method